In 900 patients with large-vessel minor ischaemic stroke or TIA on aspirin, cilostazol vs ticagrelor showed no significant difference in new stroke at 3 months (7.6% vs 6.4%; HR 1.37; P=0.21) but fewer bleeding complications (3.3% vs 6.7%).
RCTn = 900
Ismaiel et al. Ticagrelor plus aspirin versus cilostazol plus aspirin in the acute-phase treatment of large-vessel minor stroke or TIA: A randomized controlled multi-center trial, the TACTIS trial